Clinical Trial Update: RAD001 in Advanced Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial of RAD001 (everolimus) in advanced soft tissue sarcoma and bone sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Asan Medical Center | Conditions: Soft Tissue Sarcomas, Bone Sarcomas | Phase 2 | Status: COMPLETED